Hopkins researchers help secure full FDA approval to treat immunocompromised COVID-19 patients—paving the way to explore ...

This article originally appeared on the Bloomberg School of Public Health website.Researchers from the Johns Hopkins ...

Zenocutuzumab helps fill an important need for patients with advanced pancreatic cancer and NSCLC with NRG1 gene fusions, said Alison Schram M.D., ...

The publication reviews the results of 204 patients with 12 tumor types enrolled and treated on the eNRGy study, concluding “Zenocutuzumab demonstrated durable efficacy in patients with advanced NRG1+ ...

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025(Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodi ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

A human case of H5N1 avian influenza has been detected in in the UK authorities have said.  It is the second symptomatic human case of H5N1 bird flu recorded in the UK, after the first was detected in ...

The CDC has instructed its scientists to retract or pause the publication of any research manuscript being considered by any ...

Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...

Gene therapy promises individualised management of disease for each patient. Even if two individuals suffer from the same ...

Democrats undermined public trust during the pandemic. Republicans can now reassure Americans that vaccines save lives and money.

Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.